Bryn Mawr Trust CO Novo Nordisk A S Transaction History

Bryn Mawr Trust CO

  • $5.44 Billion
  • Q4 2024

A detailed history of Bryn Mawr Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Bryn Mawr Trust CO holds 19,881 shares of NVO stock, worth $1.67 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
19,881
Previous 28,999 31.44%
Holding current value
$1.67 Million
Previous $3.45 Million 50.46%
% of portfolio
0.03%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025
SELL
$85.0 - $120.04 $775,030 - $1.09 Million
-9,118 Reduced 31.44%
19,881 $1.71 Million
Q3 2024

Nov 25, 2024
BUY
$119.07 - $145.42 $1.6 Million - $1.95 Million
13,437 Added 86.34%
28,999 $3.45 Million
Q2 2024

Aug 08, 2024
SELL
$122.71 - $146.91 $58,409 - $69,929
-476 Reduced 2.97%
15,562 $2.22 Million
Q1 2024

May 14, 2024
BUY
$102.11 - $135.92 $23,689 - $31,533
232 Added 1.47%
16,038 $2.06 Million
Q3 2023

Nov 15, 2023
BUY
$90.94 - $199.54 $705,421 - $1.55 Million
7,757 Added 96.37%
15,806 $1.44 Million
Q2 2023

Aug 11, 2023
SELL
$155.98 - $172.65 $143,813 - $159,183
-922 Reduced 10.28%
8,049 $1.3 Million
Q1 2023

May 15, 2023
SELL
$132.34 - $159.14 $27,262 - $32,782
-206 Reduced 2.24%
8,971 $1.43 Million
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $155,211 - $190,478
1,629 Added 21.58%
9,177 $914,000
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $1.05 Million - $1.23 Million
-10,133 Reduced 57.31%
7,548 $841,000
Q1 2022

May 16, 2022
SELL
$93.1 - $112.54 $24,392 - $29,485
-262 Reduced 1.46%
17,681 $1.96 Million
Q4 2021

Feb 10, 2022
SELL
$95.88 - $117.08 $10,738 - $13,112
-112 Reduced 0.62%
17,943 $2.01 Million
Q2 2021

Jul 29, 2021
SELL
$67.66 - $84.76 $27,131 - $33,988
-401 Reduced 2.17%
18,055 $1.51 Million
Q1 2021

Apr 23, 2021
SELL
$67.06 - $75.82 $65,651 - $74,227
-979 Reduced 5.04%
18,456 $1.24 Million
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $8,279 - $9,128
-130 Reduced 0.66%
19,435 $1.35 Million
Q1 2020

May 08, 2020
SELL
$49.46 - $64.78 $22,652 - $29,669
-458 Reduced 2.29%
19,565 $1.18 Million
Q4 2019

Feb 11, 2020
SELL
$49.86 - $58.26 $20,691 - $24,177
-415 Reduced 2.03%
20,023 $1.16 Million
Q3 2019

Oct 24, 2019
BUY
$47.54 - $53.43 $52,864 - $59,414
1,112 Added 5.75%
20,438 $1.06 Million
Q3 2018

Nov 15, 2018
BUY
$46.76 - $51.24 $11,690 - $12,810
250 Added 1.31%
19,326 $911,000
Q2 2018

Aug 14, 2018
SELL
$44.29 - $50.42 $9,478 - $10,789
-214 Reduced 1.11%
19,076 $879,000
Q3 2017

Nov 14, 2017
BUY
$41.15 - $49.22 $793,783 - $949,453
19,290
19,290 $929,000

Others Institutions Holding NVO

# of Institutions
1,879
Shares Held
317M
Call Options Held
5.49M
Put Options Held
7.77M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $190B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email